Equity Profile

MLYS

Mineralys Therapeutics, Inc.

Health CareBiotechnology$2.3B

Aug12Wed

Pre-Earnings Brief

UpcomingQ2-2026After Close5:00 PM EDT

Company Snapshot

Mineralys Therapeutics, Inc. is a biotechnology company focused on developing innovative treatments for various health conditions....

Key Metrics to Watch

EPS

Earnings per share is a key indicator of the company's profitability and financial health.

N/A

Revenue

Revenue figures will provide insight into the company's market performance and demand for its products.

N/A

Wall Street expectations, options signals, track record, and call prep available with Pro.

MLYS Q2-2026 Earnings Preview

Context

Company Snapshot

Mineralys Therapeutics, Inc. is a biotechnology company focused on developing innovative treatments for various health conditions. Operating in the health care sector, the company is significant for its potential contributions to medical advancements and patient care.

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

75%

Avg EPS Surprise

+6.74%

Avg Stock Reaction

+5.24%

Last Quarter Recap

In the last quarter, Mineralys reported an EPS of -$0.47, which was better than the expected -$0.51, leading to a positive stock reaction of 2.87%. However, revenue details were not disclosed.

Management Promises & Guidance

Expectations

Wall Street Expectations

Investors are cautiously optimistic about the upcoming earnings report, especially given the company's history of beating EPS estimates. However, uncertainty remains due to the lack of revenue guidance.

Bull Case

If Mineralys continues its trend of beating EPS estimates, it could signal strong operational performance and boost investor confidence.

Bear Case

On the other hand, if the company fails to meet expectations or provides weak guidance, it could lead to a significant drop in stock price.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will the EPS be this quarter?

Given the company's history of beating EPS estimates, this figure will be crucial for investor sentiment.

Will there be any revenue guidance provided?

Lack of revenue guidance has created uncertainty, and any insights here could significantly impact stock performance.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating the potential for Mineralys to exceed EPS expectations based on its recent performance trends.

Supporting Evidence

The company has a 75% EPS beat rate in the last eight quarters, indicating strong operational performance.

Options pricing suggests a significant move, reflecting heightened expectations for volatility.

Recent positive surprises in EPS could indicate a trend that the market is not fully pricing in.

Key Risk

If the EPS comes in better than -$0.47, it could shift the narrative significantly.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is weighing the potential for continued EPS improvement against the uncertainty of revenue guidance.

Bull Confirmed If

Reporting an EPS better than -$0.47 would confirm the bullish sentiment.

Bear Confirmed If

An EPS worse than -$0.51 could indicate underlying issues.

Pre-Earnings Positioning

Options Market

Implied Move

±28.1%

Historical Avg

±6.1%

Pricing rich

The options market is pricing in a significant move, indicating that traders expect considerable volatility around the earnings report.

Options are pricing ±28.1% while MLYS has averaged ±6.1% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.8%

30d HV

60.3%

Calls (863K)P/C Ratio: 2.39Puts (188K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Mineralys beats expectations, history suggests a stock increase of around 5.22%, confirming positive operational momentum.

In-Line / Cautious

If results are in line with expectations, the stock may experience muted reactions as investors await further clarity.

Miss

A miss could lead to a decline, with historical patterns suggesting a drop of around 5.29%.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on product pipeline developments.
2Insights into market demand for their treatments.
3Management's commentary on operational efficiency improvements.
4Details on any partnerships or collaborations.
5Future guidance on revenue expectations.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Aug10

BWBMO

Babcock & Wilcox Enterprises, Inc.

PreviewView

Aug10

ROIVBMO

Company Snapshot

Mineralys Therapeutics, Inc. is a biotechnology company focused on developing innovative treatments for various health conditions....

Key Metrics to Watch

EPS

Earnings per share is a key indicator of the company's profitability and financial health.

N/A

Revenue

Revenue figures will provide insight into the company's market performance and demand for its products.

N/A

Wall Street expectations, options signals, track record, and call prep available with Pro.

MLYS Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

75%

Avg EPS Surprise

+6.74%

Avg Stock Reaction

+5.24%

Last Quarter Recap

In the last quarter, Mineralys reported an EPS of -$0.47, which was better than the expected -$0.51, leading to a positive stock reaction of 2.87%. However, revenue details were not disclosed.

Management Promises & Guidance

Expectations

Wall Street Expectations

Bull Case

If Mineralys continues its trend of beating EPS estimates, it could signal strong operational performance and boost investor confidence.

Bear Case

On the other hand, if the company fails to meet expectations or provides weak guidance, it could lead to a significant drop in stock price.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will the EPS be this quarter?

Given the company's history of beating EPS estimates, this figure will be crucial for investor sentiment.

Will there be any revenue guidance provided?

Lack of revenue guidance has created uncertainty, and any insights here could significantly impact stock performance.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating the potential for Mineralys to exceed EPS expectations based on its recent performance trends.

Supporting Evidence

The company has a 75% EPS beat rate in the last eight quarters, indicating strong operational performance.

Options pricing suggests a significant move, reflecting heightened expectations for volatility.

Recent positive surprises in EPS could indicate a trend that the market is not fully pricing in.

Key Risk

If the EPS comes in better than -$0.47, it could shift the narrative significantly.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is weighing the potential for continued EPS improvement against the uncertainty of revenue guidance.

Bull Confirmed If

Reporting an EPS better than -$0.47 would confirm the bullish sentiment.

Bear Confirmed If

An EPS worse than -$0.51 could indicate underlying issues.

Pre-Earnings Positioning

Options Market

Implied Move

±28.1%

Historical Avg

±6.1%

Pricing rich

The options market is pricing in a significant move, indicating that traders expect considerable volatility around the earnings report.

Options are pricing ±28.1% while MLYS has averaged ±6.1% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.8%

30d HV

60.3%

Calls (863K)P/C Ratio: 2.39Puts (188K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Mineralys beats expectations, history suggests a stock increase of around 5.22%, confirming positive operational momentum.

In-Line / Cautious

If results are in line with expectations, the stock may experience muted reactions as investors await further clarity.

Miss

A miss could lead to a decline, with historical patterns suggesting a drop of around 5.29%.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on product pipeline developments.
2Insights into market demand for their treatments.
3Management's commentary on operational efficiency improvements.
4Details on any partnerships or collaborations.
5Future guidance on revenue expectations.